- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-7961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Angioedema associated with dipeptidyl peptidase-IV inhibitors ; volume:19 ; number:1 ; day:6 ; month:12 ; year:2021 ; pages:1-12 ; date:12.2021
Clinical and molecular allergy ; 19, Heft 1 (6.12.2021), 1-12, 12.2021
- Creator
-
Cassano, Nicoletta
Nettis, Eustachio
Di Leo, Elisabetta
Ambrogio, Francesca
Vena, Gino A.
Foti, Caterina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12948-021-00164-7
- URN
-
urn:nbn:de:101:1-2022013118381135436854
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cassano, Nicoletta
- Nettis, Eustachio
- Di Leo, Elisabetta
- Ambrogio, Francesca
- Vena, Gino A.
- Foti, Caterina
- SpringerLink (Online service)
Other Objects (12)
Development of dipeptidyl peptidase 8 and 9 inhibitors
Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Development of dipeptidyl peptidase 8 and 9 inhibitors
Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Development of dipeptidyl peptidase 8 and 9 inhibitors
Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie